ERBB2 and cancer: Consistent with the above finding, the potency (IC50) and efficacy (maximum effect on cell viability) results showed that the antitumor efficacy of RC48‐ADC in cancer cell lines was positively correlated with HER2 expression level (Figure 2b; Table S1, Supporting Information).